Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2004

Conditions
Prostate Cancer
Interventions
PROCEDURE

quality-of-life assessment

Trial Locations (13)

10021

Memorial Sloan-Kettering Cancer Center, New York

14642

James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester

23507

Sentara Norfolk General Hospital, Norfolk

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

63110

Washington University School of Medicine, St Louis

94143-0128

UCSF Comprehensive Cancer Center, San Francisco

20307-5000

Walter Reed Army Medical Center, Washington D.C.

52242-1062

Holden Comprehensive Cancer Center at University of Iowa, Iowa City

02215

Beth Israel Deaconess Medical Center, Boston

28233-3549

Presbyterian Hospital, Charlotte

05401

Fletcher Allen Health Care - Medical Center Campus, Burlington

98195-6043

University Cancer Center at University of Washington Medical Center, Seattle

98431-5048

Madigan Army Medical Center, Tacoma

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00052481 - Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate Cancer | Biotech Hunter | Biotech Hunter